ATE54757T1 - Verfahren zum nachweis von htlv-iii neutralisierenden antikoerpern in sera. - Google Patents

Verfahren zum nachweis von htlv-iii neutralisierenden antikoerpern in sera.

Info

Publication number
ATE54757T1
ATE54757T1 AT86300600T AT86300600T ATE54757T1 AT E54757 T1 ATE54757 T1 AT E54757T1 AT 86300600 T AT86300600 T AT 86300600T AT 86300600 T AT86300600 T AT 86300600T AT E54757 T1 ATE54757 T1 AT E54757T1
Authority
AT
Austria
Prior art keywords
sera
iii
procedure
htlv
neutralizing antibodies
Prior art date
Application number
AT86300600T
Other languages
English (en)
Inventor
Marjorie Robert Guroff
Robert Charles Gallo
Original Assignee
Us Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Commerce filed Critical Us Commerce
Application granted granted Critical
Publication of ATE54757T1 publication Critical patent/ATE54757T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1143—Gag-pol proteins, e.g. p17or p24

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT86300600T 1985-02-05 1986-01-29 Verfahren zum nachweis von htlv-iii neutralisierenden antikoerpern in sera. ATE54757T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69858885A 1985-02-05 1985-02-05
EP86300600A EP0193284B1 (de) 1985-02-05 1986-01-29 Verfahren zum Nachweis von HTLV-III neutralisierenden Antikörpern in Sera

Publications (1)

Publication Number Publication Date
ATE54757T1 true ATE54757T1 (de) 1990-08-15

Family

ID=24805871

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86300600T ATE54757T1 (de) 1985-02-05 1986-01-29 Verfahren zum nachweis von htlv-iii neutralisierenden antikoerpern in sera.

Country Status (9)

Country Link
EP (1) EP0193284B1 (de)
JP (1) JPS61502910A (de)
AT (1) ATE54757T1 (de)
AU (1) AU577937B2 (de)
CA (1) CA1271417A (de)
DE (1) DE3672624D1 (de)
IE (1) IE860315L (de)
NZ (1) NZ214979A (de)
WO (1) WO1986004613A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716102A (en) * 1984-08-15 1987-12-29 Regents Of The University Of California Purified AIDS-associated virus ARV-2
US4753873A (en) * 1986-02-03 1988-06-28 Cambridge Bioscience Corporation Peptides for the diagnosis of HTLV-III antibodies, their preparation and use
US4863730A (en) * 1986-03-21 1989-09-05 Cenfold Holdings, S.A. Immunotherapy for AIDS patients
US5166050A (en) * 1986-08-20 1992-11-24 Bristol-Myers Squibb Company Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
ES2102347T3 (es) 1987-02-20 1997-08-01 Genentech Inc Metodos y composiciones para la utilizacion de polipeptidos env y anticuerpos anti-env de hiv.
FR2615623B1 (fr) * 1987-05-22 1992-06-19 Transgene Sa Test de diagnostic du sida base sur la mise en evidence d'une diversite de la reponse isotypique, vaccins et serotherapies
US6657050B1 (en) * 1987-05-29 2003-12-02 Tanox, Inc. Chimeric viral-neutralizing immunoglobulins
AU618555B2 (en) * 1987-08-11 1992-01-02 Biomune Corporation Hyper-immune globulin against hiv
EP0356007A3 (de) * 1988-07-22 1991-07-03 Medical Research Council Antigenische Determinanten
DE4039925A1 (de) * 1990-12-14 1992-06-17 Behringwerke Ag Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung
EP1751115A4 (de) 2004-05-23 2010-10-20 Gerard M Housey Theramuteinmodulatoren
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7609183A (nl) * 1975-09-04 1977-03-08 Merck & Co Inc Werkwijze voor het bepalen van de infectiviteit van viruspreparaten en werkwijze voor het be- palen van het antilichaamgehalte van serum.
NZ228756A (en) * 1984-04-23 1990-10-26 Us Health Detection of hiv antigen using competition immune assay or western blot assay
US4520113A (en) * 1984-04-23 1985-05-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions
CA1254118A (en) * 1984-12-28 1989-05-16 The United States Of America, Represented By The Secretary, U.S. Departm Ent Of Commerce In situ detection of human t-cell leukemia virus type iii
NL8620004A (nl) * 1985-01-15 1986-12-01 Cancer Res Inst Verbeteringen met betrekking tot virale isolaten en toepassing daarvan.

Also Published As

Publication number Publication date
AU5454586A (en) 1986-08-26
EP0193284B1 (de) 1990-07-18
AU577937B2 (en) 1988-10-06
IE860315L (en) 1986-08-05
WO1986004613A1 (en) 1986-08-14
NZ214979A (en) 1988-05-30
EP0193284A1 (de) 1986-09-03
JPS61502910A (ja) 1986-12-11
DE3672624D1 (de) 1990-08-23
CA1271417A (en) 1990-07-10

Similar Documents

Publication Publication Date Title
ZA853025B (en) Isolation of proteins of htlv-iii,serological detection of antibodies to htlv-iii in sera of patients with aids and pre-aids conditions,and detection of htlv-iii infection by immuno-assays using htlv-iii and its proteins
NZ228756A (en) Detection of hiv antigen using competition immune assay or western blot assay
DE3876496D1 (de) Synthetisches peptid-antigen fuer nachweis von hiv-2-infektionen.
EA200100943A1 (ru) Вич-пептиды, антигены, вакцинные композиции, набор для иммуноанализа и способ определения вич-индуцированных антител
ATE364621T1 (de) Hiv-peptide
DK0386882T3 (da) Pakningsdefekt HIV-provirus, cellelinier og anvendelse heraf
ATE54757T1 (de) Verfahren zum nachweis von htlv-iii neutralisierenden antikoerpern in sera.
ES2016426A6 (es) Un procedimiento para detectar la presencia de anticuerpos frente a virus del sida en el suero humano.
GB2154609B (en) Hcmv monoclonal antibodies and their use in the detection of hcmv infection and hcmv specific igm, and methods of detecting viral antigens
DE69013950D1 (de) Monoklonaler Antikörper zur Unterscheidung HIV-2-seropositiver von HIV-1-seropositiven Individuen.
DK157186A (da) Ekspression af immunologisk aktive virale proteiner
DE3579856D1 (de) Immunulogischer test zur bestimmung von gemeinsamen, bestimmenden hepatitis-b-antikoerpern.
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
SE8203909L (sv) Bestemning av virus kenslighet for antivirala medel
Levitt et al. Solid-Phase Radioimmunossay for Rapid Detection and Identification of Western Equine Encephalomyelitis Virus
DK0674718T3 (da) Fremgangsmåde til identifikation af individer smittet med HIV og overvågning af deres terapi
SU1545614A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus, используемый для получения моноклональных антител к белку е оболочки вирусов комплекса клещевого энцефалита
SU1692146A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus l. - продуцент моноклональных антител к 146 s-компоненту вируса ящура o
ATE130050T1 (de) Verfahren zum schnellen und empfindlichen nachweis von hiv-1-antikörpern.
SU1533329A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus, используемый для получения моноклональных антител к белку е оболочки вирусов комплекса клещевого энцефалита
UA8704A1 (uk) Спосіб визhачеhhя аhтигеhhої hовими вірусу грипу
EP0365172A3 (de) Nachweis von anti-pre-S-Antikörpern

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee